Distribution of perospirone to melanin in pigmented rats

  • Yoshiko Mizuno
  • Setsuko Komuro
  • Hiroshi Kanamaru


Following the administration of [Carbonyl-14C]perospirone ([CO-14C]perospirone) and [isothiazolyl-3-14C]perospirone ([TH-14C]perospirone) to male-pigmented rats at a single oral dose of 10 mg/kg, serum radioactivity reached maxima of 499 ng eq./g and 446 ng eq./g, respectively, at 1 hour, then decreased rapidly to below 2 ng eq./g at 168 hours, and radioactivity in eyeballs reached maxima of 576 ng eq./g and 3449 ng eq./g, respectively, at 24 hours, then decreasing slowly to become 120 ng eq./g and 314 ng eq./g at 26 weeks. Apparent elimination half-lives of radioactivity in eyeballs were 197 and 126 days for [CO-14C]perospirone and [TH-14C]perospirone, respectively. With radioluminograms, radioactivity was detected specifically in the uvea, reaching maxima at 168 hours for [CO-14C]perospirone and at 24 hours for [TH-14C]perospirone.

In addition to unchanged compound, many metabolites were found in serum and eyeballs, but those were also detectable in SD albino rats and cynomolgus monkeys. Among radioactive components in eyeballs after administration of [CO-14C]perospirone, ratios of ID-15036 and MX11 followed by unchanged compound and MX9 are high. After administration of [TH-14C]perospirone ID-11614 accounted for nearly half of the radioactivity. Values decreased in line with radioactivity in eyeballs over time and 26 weeks only a few polar metabolites could be detected.


Perospirone melanin distribution rat 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hirose A., Kato T., Ohno Y., Shimizu H., Tanaka H., Nakamura M., Katsube J. (1990): Pharmacological Actions of SM-9018, a New Neuroleptic Drug with Both Potent 5-Hydroxytryptamine2 and Dopamine2 Antagonistic Actions. Japan. J. Pharmacol., 53, 321–329.Google Scholar
  2. 2.
    Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Disposition of SM-9018 after Single Oral Administration to Rats and Protein Binding to Serum of Human and Animals. Clinical Report, 31(2), 543–568.Google Scholar
  3. 3.
    Mizuno Y., Kanamaru H., Nakatsuka I., Miyoshi K., Hanawa S., Hayashi K., Esumi Y. (1997): Disposition of [carbonyl-14C]SM-9018 in Cynomolgus monkeys. Clinical Report, 31(2), 799–809.Google Scholar
  4. 4.
    Mizuno Y., Kanamaru H., Nakatsuka I., Kitajima S., Mitsuoka C., Kodama R. (1997): Disposition of [isothiazolyl-14C] SM-9018 in Cynomolgus monkeys. Clinical Report, 31(2), 811–819.Google Scholar
  5. 5.
    Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Metabolic Profile in Serum after Single Oral Administration of14C-SM-9018 to Rats. Clinical Report, 31(2), 689–705.Google Scholar
  6. 6.
    Fujimoto K., Mizuno Y., Kanamaru H., Nakatsuka I. (1997): Identification of Metabolites of SM-9018. Clinical Report, 31(2), 581–657.Google Scholar
  7. 7.
    Ings R. M. J. (1984): The Melanin Binding of Drugs and its Implications. Drug Metab. Rev., 15, 1183–1212.CrossRefPubMedGoogle Scholar
  8. 8.
    Salazar-Bookaman M. M., Wainer I., Patil P. N. (1994): Relevance of drug-melanin interactions to ocular pharmacology and toxicology. J. Ocular Pharmacol., 10, 217–239.CrossRefGoogle Scholar
  9. 9.
    Leblanc B., Jezequel S., Davies T., Hanton G., Taradach C. (1998): Binding of Drugs to Eye Melanin Is Not Predictive of Ocular Toxicity. Reg. Toxicol. Pharmacol., 28, 124–132.CrossRefGoogle Scholar
  10. 10.
    Butler W. H., Ford G. P., Newberne J. W. (1987): A study of the effects of vigabatrin on the central nervous system and retina of Sprague-Dawley and Lister-hooded rats. Toxicol. Pathol., 15, 143–148.CrossRefPubMedGoogle Scholar
  11. 11.
    Render J. A., Carlton W. W. (1985): Ocular lesions of 6-aminonicotinamide toxicosis in rabbits. Vet. Pathol., 22, 72–77.PubMedGoogle Scholar
  12. 12.
    Santos-Anderson R. M., Tso M. O., Valdes J. J., Annau Z. (1984): Chronic lead administration in neonatal rats: Electron microscopy of the retina. J. Neuropathol. Exp. Neurol., 43, 175–187.CrossRefPubMedGoogle Scholar
  13. 13.
    Lullman-Rauch R. (1991): Lipidosis of the retina due to catinic amtiphilic drugs, rat. In: T. C. Jones, U. Mohr, and R. D. Hunt, (Eds). Eye and Ear, Monographs on Pathology of Laboratory Animals. Berlin: Springer-Verlag, 87–92.Google Scholar
  14. 14.
    Meier-Ruge W., Cerletti A. (1966): Zur Experimentellen Pathologie der Phenothiazin-retinopathie. Ophthalmologica, 151, 512–533.CrossRefPubMedGoogle Scholar
  15. 15.
    Kuhn H., Keller P., Kovacs E., Steiger A. (1981): Lack of Correlation Between Melanin Affinity and Retinopathy in Mice and Cats Treated with Chloroquine or Flunitorazepam. Albrechit Von Graefes Arch. Klin. Ophthalmol., 216, 177–190.CrossRefGoogle Scholar
  16. 16.
    Yamada T., Yamaguchi T., Miyata K., Inoue T., Nakayama Y., Yoshioka K., Kamita Y., Seki T., Okuno Y., Hosokawa T. (1997): Twelve-month Repeated Oral Toxicity Study of SM-9018 in Rats. Clinical Report, 31(2), 309–358.Google Scholar
  17. 17.
    Koizumi H., Konishi H., Suzuki S., Hirata M. (1990): Thirteen-weeks Repeated Oral Toxicity Study with Four-weeks Recovery Period of perospirone in Monkeys. Preclinical Research Laboratories, Inc. inhouse report.Google Scholar
  18. 18.
    Koizumi H., Konishi H., Suzuki S., Hirata M. (1993): Fifty-two-weeks Repeated Oral Toxicity Study of perospirone in Monkeys. Preclinical Research Laboratories, Inc. in-house report.Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Yoshiko Mizuno
    • 1
  • Setsuko Komuro
    • 1
  • Hiroshi Kanamaru
    • 1
  1. 1.Environmental Health Science LaboratorySumitomo Chemical Co., Ltd.OsakaJapan

Personalised recommendations